Introduction
Chlormethiazole is a sedative and hypnotic with marked anti-convulsant properties. It is widely used in the treatment of states characterized by convulsions and agitation, including delirium tremens. Although rarely causing side effects, the drug has been shown to depress the respiratory centre (Lechat, 1966) and toxic interactions with alcohol have been found in animals (Vapaatalo and Karppanen, 1969) . Sudden deaths ascribed to chlormethiazole therapy have been attributed to respiratory depression, and alcohol abuse seems to be a predisposing factor (Pentikainen, Valtonen and Miettinen, 1976 asystole following a one-hr infusion of 100 ml 0.800 chlormethiazole, its only administration in the previous 24 hr. Resuscitation was unsuccessful. The only other drug treatment was 10 mg of diazepam in divided doses in the 6 hr before death. At postmortem, the findings were an insignificant pulmonary embolus and focal fatty hepatic degeneration consistent with chronic alcoholism. Total dose of chlormethiazole was 9-4 g, 6 9 g by infusion; tissue concentration was 0-65 mg/100 g liver.
Discussion
The association between chlormethiazole therapy and cardiac arrest is impressive. The only other drugs given for several hours were antibiotics and diazepam in small doses to the second patient. The combination of chlormethiazole and other sedatives has been implicated in the development of respiratory depression (Pentikainen et al., 1976) . There was no evidence of this in either case.
The manufacturer's recommended maintenance dose of chlormethiazole is 333-1333 mg/hr. At the times of arrest in the 2 patients, the infusion rates were 667 mg/hr and 600 mg/hr respectively. At these rates, significant accumulation should not occur on long term administration since the elimination halflife is short (Moore et al., 1975) . However, chlormethiazole pharmacokinetics are age-dependent and the drug undergoes hepatic clearance (Nation et al., 1976). Thus, in older patients with hepatic insufficiency, as in these 2 cases, lower doses may be desirable. Nonetheless, the tissue concentration in the fatal case suggests that the infusion rate was appropriate. Quality control studies on the chlormethiazole used in that patient failed to identify any adulterants which might have contributed to his death.
It seems unlikely that the incidents reported were due simply to acute withdrawal of alcohol from chronic alcoholics. Unexpected deaths have been reported in such patients but the incidence is extremely low and the absence of preliminary signs makes this unlikely (Shaw, 1978) . However, potassium concentrations decline during acute withdrawal from alcohol (Wadstein and Skude, 1978) and low serum potassium may be associated with cardiac arrhythmias (Dyckner, Helmers and Wester, 1975; Duke, 1978) . In neither of these patients was serum potassium known at the time of arrests but a low concentratioin might have contributed to an adverse cardiovascular effect of chlormethiazole.
Sudden withdrawal of n-blockers from patients with coronary artery disease is infrequently followed by acute coronary syndromes (Mizgala and Counsell, 1976; Williams, Turney and Parsons, 1979) although a recent prospective study has questioned this (Myers et al., 1979) . Such events are unlikely to follow abrupt cessation in patients receiving these drugs for hypertension (Maling and Dollery, 1979) . In the first case reported here, compliance with atenolol given for hypertension may have been incomplete but there is no evidence of sudden discontinuation nor resultant coronary insufficiency. Cohen et al. (1979) 
